Search

everythinglearnresearchcommunity

for

Search:↓

Amelanotic melanocytes from hair follicles are immature and likely don't transfer melanosomes to keratinocytes.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

The document concludes that treatment can improve hair growth and symptoms in Fibrosing Alopecia in a Pattern Distribution.

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

Autologous growth factor concentrate therapy shows promise for treating early-stage hair loss safely and effectively.

The Dfl mutation in mice causes poor sebaceous gland function and complete hair loss.

Infliximab successfully treated a severe hair loss case in Sri Lanka.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

A new group called the Asian Association of Hair Restoration Surgeons (AAHRS) has been created.

Cosmetic products or emotional factors might contribute to Frontal Fibrosing Alopecia, and trichoscopy is useful for diagnosis.

Oral tofacitinib is more effective than oral minoxidil for treating alopecia areata.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

Scarring hair loss found in female pattern; biopsy needed for diagnosis.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Dermoscopic features can help distinguish female androgenetic alopecia from telogen effluvium and healthy controls.

A patient with hair loss condition grew excessive hair in areas covered by a cast.

Trichoscopy is useful for diagnosing Frontal Fibrosing Alopecia.

The authors suggest a method for hair transplantation in fibrosing alopecia pattern distribution to improve treatment outcomes and cover bald areas.

Aromatase gene variation may increase female hair loss risk.

Intralesional triamcinolone acetonide is effective and safe for treating early to mid-stage traction alopecia.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Pityriasis amiantacea is a scalp condition with thick, greasy scales and sometimes hair loss.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.